查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1782005

ELISA 诊断测试市场（按测试类型、按应用、按最终用户、按国家和地区）－2025 年至 2032 年全球产业分析、市场规模、市场份额及预测

ELISA Diagnostics Tests Market, By Test Type, By Application, By End User, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032
出版日期: | 出版商: AnalystView Market Insights | 英文 269 Pages | 商品交期: 2-3个工作天内

价格
简介目录

报告重点

2024 年 ELISA 诊断测试市场规模价值 16.9032 亿美元，2025 年至 2032 年的复合年增长率为 5.93%。

ELISA 诊断测试市场-市场动态

日益加重的疾病负担增加了对早期诊断的需求

全球传染病和慢性病的增加推动了对早期精准诊断方法的需求。 ELISA 检测至关重要，因为它们能够在疾病早期检测出特定的蛋白质、抗原和抗体。赛默飞世尔科技和 Bio-Rad Laboratories 等公司通常使用 ELISA 试剂盒进行早期 HIV 检测。这有助于改善患者预后并减少传播。在新冠疫情期间，雅培公司研发了基于 ELISA 的抗体检测方法，用于识别既往感染。这不仅支持了公共卫生工作，也促进了疫苗的分发。此外，Bio-Techne 还提供 PSA 和 CA-125 等癌症生物标记的 ELISA 试剂盒。这些试剂盒有助于早期诊断和治疗监测。这些案例表明，疾病数量的增加正在推动全球对 ELISA 诊断检测的需求。医疗保健系统正致力于寻找灵敏、经济且可靠的早期疾病检测和管理工具。

例如，

2021年10月，西门子医疗推出了一种基于ELISA的新型检测方法，旨在早期检测自体免疫疾病，以应对全球范围内类风湿性关节炎和狼疮等疾病日益增长的患病率。该产品的推出有助于临床医生更早诊断这些复杂的疾病，从而改善患者管理。

ELISA 诊断测试市场—关键见解

根据我们的研究分析师的分析，预测期内（2025-2032 年）全球市场预计年复合成长率约为 5.93%

根据测试类型细分，预计夹心 ELISA 将在 2024 年占据最大市场份额

根据应用细分，传染病是 2024 年的主要应用

按地区划分，北美是 2024 年的主要收入来源

ELISA 诊断测试市场-細項分析：

全球 ELISA 诊断测试市场根据测试类型、应用程式、最终用户和地区进行细分。

根据检测类型，市场可分为四类：竞争性 ELISA、间接 ELISA、多重及便携式 ELISA 和夹心 ELISA。夹心 ELISA 占据市场主导地位，这得益于其相比其他 ELISA 模式具有更优异的灵敏度和特异性。此方法将目标抗原捕获在两层抗体之间，从而提高了检测血液或血清等复杂样本中低浓度生物标记的准确性。由于这些优势，夹心 ELISA 广泛应用于临床诊断，应用范围广泛，包括传染病检测、癌症生物标记识别和荷尔蒙水平测量。其可靠性和提供定量结果的能力使其成为医疗保健提供者和研究实验室的首选。

根据最终用户，市场可分为三类：医院和诊断中心、製药和生物技术公司、兽医院和诊断实验室。医院和诊断中心占据市场主导地位。这种主导地位源自于ELISA检测在临床疾病诊断、监测和筛检的广泛应用。医院和诊断中心需要可靠、快速的检测解决方案来管理传染病、慢性病和其他健康问题，这使得它们成为ELISA试剂盒及相关产品的最大消费者。他们对精准、高通量诊断工具的持续需求，确保了该细分市场相对于製药公司和兽医院诊实验室占据最大的市场份额。

ELISA 诊断测试市场-地理洞察

在 2024 年的预测期内，北美将主导全球 ELISA 诊断测试市场。

北美在 ELISA 诊断检测市场中占据最大份额。这主要得益于其强大的医疗基础设施和大量的诊断检测。该地区受益于政府和私营部门在医学研究和公共卫生方面的大量投资。赛默飞世尔科技、雅培和伯乐实验室等主要企业推动持续创新，并促进了高品质 ELISA 试剂盒和仪器的普及。美国和加拿大的医院和实验室普遍使用 ELISA 检测来诊断各种传染病和慢性病。此外，人们对早期疾病检测的高度认知和优惠的报销政策也有助于推广这些检测。这些因素共同作用，使北美成为该市场的领先地区。

预计在 2024 年的预测期内，亚太地区 ELISA 诊断测试市场的复合年增长率最高。

亚太地区是ELISA诊断检测市场成长最快的地区。这一增长源于传染病和生活方式相关疾病的增加。中国、印度和东南亚等国家正在扩大医疗基础建设，并增加对诊断技术的投入。医护人员和民众对早期诊断重要性的认识日益加深，这推动了对ELISA检测的需求。政府健康倡议和大型筛检计画也正在推广使用像ELISA这样可靠的诊断工具。此外，ELISA试剂盒价格低廉，在註重预算的医疗机构中颇受欢迎。这些因素正在推动该地区市场显着成长。

ELISA 诊断测试市场-竞争格局：

ELISA 诊断检测市场竞争激烈，全球和本地企业均专注于产品创新、建立合作伙伴关係并扩大业务范围。赛默飞世尔科技、雅培、Bio-Rad Laboratories、丹纳赫集团（贝克曼库尔特）和罗氏製药等知名企业处于领先地位。他们拥有丰富的 ELISA 检测产品组合和强大的全球分销网络。这些公司在研发方面投入巨资，旨在打造灵敏度更高、自动化程度更高、用户友好的 ELISA 系统，以用于临床和研究应用。 Bio-Techne、RayBiotech、OriGene Technologies 和 Elabscience 等新兴和中型公司也日益受到关注。他们专注于特定疾病领域，并提供客製化检测开发服务。此外，金斯瑞生物科技和欧陆科技等公司正透过合作和本地製造业务拓展亚太和欧洲市场。

多重 ELISA、便携式 ELISA 平台和自动化系统等技术创新进一步塑造了这一竞争格局。随着疾病盛行率的上升以及早期诊断需求的迫切性，竞争也愈演愈烈。各公司都注重经济实惠、速度和准确性。

最新动态：

2024年5月，默克集团宣布以约6亿美元收购Mirus Bio。此次收购不仅专注于病毒载体生产，也增强了默克的下游分析能力，包括基于ELISA的平台。此次收购支持了默克的策略愿景，即增强其生命科学产品组合，并推进基因治疗和生物製程诊断领域的解决方案。

2023年4月，赛默飞世尔科技公司推出了新一代ELISA试剂盒平台，旨在为临床和研究环境提供更高的灵敏度和更快的结果。新试剂盒采用先进的讯号检测技术，可缩短检测时间并提高各种生物标记分析的一致性。此次发布彰显了赛默飞世尔科技持续致力于提高全球实验室诊断精准度和营运效率的承诺。

2023 年 2 月，Abcam plc 推出一系列基于重组单株抗体的全新 ELISA 试剂盒，扩展了其 ELISA 产品组合。这些试剂盒专为癌症和自体免疫疾病研究而设计，可在实验中提供更高的特异性和一致性。此次发布彰显了 Abcam 对可重复性和高品质研究工具的承诺，旨在满足学术界和生物製药研究界日益增长的需求。

2023年2月，默克集团旗下生命科学部门MilliporeSigma推出了专为临床前研究中检测细胞激素和趋化因子而设计的多重ELISA试剂盒。这些试剂盒能够同时测量多种分析物，进而提升资料深度和检测效率。此次推出的试剂盒增强了默克在诊断和生命科学领域的影响力，满足了生物标记发现和转化研究中对先进工具日益增长的需求。

目录

第 1 章：ELISA 诊断测试市场概述

  • 研究范围
  • 市场估计年限

第二章：执行摘要

  • 市场片段
    • ELISA 诊断测试市场片段（依测试类型）
    • ELISA 诊断测试市场片段（按应用）
    • ELISA 诊断测试市场片段（按最终用户）
    • ELISA 诊断测试市场（按国家/地区）
    • ELISA 诊断测试市场（按地区）
  • 竞争洞察

第三章：ELISA 诊断测试主要市场趋势

  • ELISA 诊断测试市场驱动因素
    • 市场驱动因素的影响分析
  • ELISA 诊断测试市场限制
    • 市场限制的影响分析
  • ELISA 诊断测试市场机会
  • ELISA 诊断测试市场未来趋势

第四章：ELISA 诊断测试产业研究

  • PESTEL分析
  • 波特五力分析
  • 成长前景图
  • 规范架构分析

第五章：ELISA 诊断测试市场：地缘政治紧张局势升级的影响

  • COVID-19 疫情的影响
  • 俄乌战争的影响
  • 中东衝突的影响

第六章：ELISA 诊断测试市场格局

  • 2024 年 ELISA 诊断测试市场占有率分析
  • 按主要製造商分類的细分数据
    • 成熟玩家分析
    • 新兴企业分析

第七章：ELISA 诊断测试市场 - 按测试类型

  • 概述
    • 按测试类型分類的细分市场份额分析
    • 竞争性 ELISA
    • 间接 ELISA
    • 多重及便携式 ELISA
    • 夹心 ELISA

第 8 章：ELISA 诊断测试市场 - 按应用

  • 概述
    • 按应用细分市场占有率分析
    • 免疫学
    • 发炎
    • 传染病
    • 癌症
    • 蛋白质定量
    • 其他应用

第九章：ELISA 诊断测试市场 - 按最终用户

  • 概述
    • 按最终用户细分的份额分析
    • 医院和诊断中心
    • 製药和生物技术公司
    • 兽医院和诊断实验室

第 10 章：ELISA 诊断测试市场 - 按地理划分

  • 介绍
    • 按地区分類的细分市场占有率分析
  • 北美洲
    • 概述
    • 北美 ELISA 诊断测试主要製造商
    • 北美市场规模及预测（按国家/地区）
    • 北美市场规模和预测（按测试类型）
    • 北美市场规模和预测（按应用）
    • 北美市场规模和预测（按最终用户）
    • 我们
    • 加拿大
  • 欧洲
    • 概述
    • 欧洲ELISA诊断测试主要製造商
    • 欧洲市场规模及预测（按国家/地区）
    • 欧洲市场规模和预测（按测试类型）
    • 欧洲市场规模和预测，按应用
    • 欧洲市场规模和预测（按最终用户）
    • 德国
    • 英国
    • 法国
    • 义大利
    • 西班牙
    • 荷兰
    • 瑞典
    • 俄罗斯
    • 波兰
    • 欧洲其他地区
  • 亚太地区 (APAC)
    • 概述
    • 亚太地区 ELISA 诊断测试主要製造商
    • 亚太地区市场规模及预测（依国家）
    • 亚太地区市场规模及预测（依测试类型）
    • 亚太地区市场规模及预测（按应用）
    • 亚太地区市场规模及预测（依最终用户）
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 印尼
    • 泰国
    • 菲律宾
    • 亚太地区其他地区
  • 拉丁美洲（LATAM）
    • 概述
    • 拉丁美洲 ELISA 诊断测试主要製造商
    • 拉丁美洲市场规模及预测（按国家/地区）
    • 拉丁美洲市场规模及预测（按测试类型）
    • 拉丁美洲市场规模及预测（按应用）
    • 拉丁美洲市场规模及预测（按最终用户）
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥伦比亚
    • 拉丁美洲其他地区
  • 中东和非洲（MEA）
    • 概述
    • ELISA 诊断测试中东和非洲主要製造商
    • MEA 市场规模及预测（依国家/地区）
    • MEA 市场规模及预测（依测试类型）
    • MEA 市场规模及预测（按应用）
    • MEA 市场规模和预测（按最终用户）
    • 沙乌地阿拉伯
    • 阿联酋
    • 以色列
    • 土耳其
    • 阿尔及利亚
    • 埃及
    • MEA 其余地区

第 11 章：关键供应商分析 - ELISA 诊断测试产业

  • 竞争基准化分析
    • Competitive Dashboard
    • Competitive Positioning
  • 公司简介
    • Abbott
    • Abcam Limited
    • BD
    • Bio-Rad Laboratories, Inc.
    • Bio-Techne Corporation
    • BioVision, Inc.
    • Creative Diagnostics
    • Danaher Corporation
    • Elabscience Biotechnology Inc.
    • Enzo Biochem, Inc.
    • Eurofins Scientific SE
    • F. Hoffmann-La Roche Ltd
    • GenScript Biotech Corporation
    • Merck KGaA
    • MyBioSource, Inc.
    • OriGene Technologies, Inc.
    • PerkinElme.
    • RayBiotech, Inc.
    • Siemens Healthineers AG
    • Thermo Fisher Scientific Inc.
    • Others

第 12 章：360 度分析师视角

第 13 章：附录

  • 研究方法
  • 参考
  • 缩写
  • 免责声明
  • 联络我们
简介目录
Product Code: ANV5445

REPORT HIGHLIGHT

ELISA Diagnostics Tests Market size was valued at US$ 1,690.32 Million in 2024, expanding at a CAGR of 5.93% from 2025 to 2032.

The global Enzyme-Linked Immunosorbent Assay (ELISA) market revolves around a diagnostic test designed to detect and measure antibodies in biological samples. By using this test, one can ascertain whether the sample has antibodies against or linked to a particular antigen associated with an infectious disease. As an immunogenic reaction to dangerous chemicals known as pathogens, proteins called antibodies are created to fight invading diseases. The biological process of ELISA involves the adsorption of an antigen onto a solid surface. An enzyme-linked antibody is permitted to be present with the antigen and is identified by the addition of an enzyme specific substrate. The ELISA test is crucial for diagnosing viral illnesses such syphilis, rotavirus, Zika virus, HIV, and the varicella zoster virus, which causes shingles and chickenpox. It is commonly used as a preliminary screening method before more detailed tests and also has applications in pharmaceutical quality control, including endotoxin detection and protein quantification.

ELISA Diagnostics Tests Market- Market Dynamics

Growing disease burden increases demand for early diagnostics

The rise of infectious and chronic diseases worldwide drives the need for early and accurate diagnostic methods. ELISA tests are vital because they can detect specific proteins, antigens, and antibodies early in the disease process. Companies like Thermo Fisher Scientific and Bio-Rad Laboratories commonly use ELISA kits for early HIV detection. This helps improve patient outcomes and reduce transmission. During the COVID-19 pandemic, Abbott created ELISA-based antibody tests to identify prior infections. This supported public health efforts and helped with vaccine distribution. Additionally, Bio-Techne provides ELISA kits for cancer biomarkers like PSA and CA-125. These kits aid in early diagnosis and treatment monitoring. These examples show how the rising number of diseases is increasing the global demand for ELISA diagnostic tests. Healthcare systems are focusing on sensitive, affordable, and reliable tools for early disease detection and management.

For Instance,

In October 2021, Siemens Healthineers launched a new ELISA-based assay designed for the early detection of autoimmune diseases, responding to the rising global prevalence of conditions like rheumatoid arthritis and lupus. This launch helps clinicians diagnose these complex diseases earlier, improving patient management.

ELISA Diagnostics Tests Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 5.93% over the forecast period (2025-2032)

Based on test type segmentation, sandwich ELISA was predicted to show maximum market share in the year 2024

Based on application segmentation, infectious diseases was the leading application in 2024

On the basis of region, North America was the leading revenue generator in 2024

ELISA Diagnostics Tests Market- Segmentation Analysis:

The global ELISA diagnostics tests market is segmented on the basis of test type, application, end user, and region.

The market is divided into four categories based on test type: competitive ELISA, indirect ELISA, multiple & portable ELISA, sandwich ELISA. The sandwich ELISA sector dominates the market. This is due to its superior sensitivity and specificity compared to other ELISA formats. This method involves capturing the target antigen between two layers of antibodies, which enhances the accuracy of detecting low concentrations of biomarkers in complex samples such as blood or serum. Because of these advantages, Sandwich ELISA is extensively used in clinical diagnostics for a wide range of applications including infectious disease detection, cancer biomarker identification, and hormone level measurement. Its reliability and ability to provide quantitative results make it the preferred choice among healthcare providers and research laboratories.

The market is divided into three categories based on end user: hospitals & diagnostic centers, pharmaceutical & biotechnology companies, veterinary hospitals & diagnostic laboratories. Hospitals & diagnostic centers dominates the market. This dominance is driven by the widespread use of ELISA tests in clinical settings for disease diagnosis, monitoring, and screening. Hospitals and diagnostic centers require reliable and rapid testing solutions to manage infectious diseases, chronic conditions, and other health concerns, making them the largest consumers of ELISA kits and related products. Their continuous demand for accurate and high throughput diagnostic tools ensures that this segment holds the largest market share compared to pharmaceutical companies and veterinary diagnostic laboratories.

ELISA Diagnostics Tests Market- Geographical Insights

North America dominates the global ELISA diagnostics tests market during the forecast period in 2024.

North America has the largest share in the ELISA Diagnostic Tests market. This is mainly due to its strong healthcare infrastructure and high volumes of diagnostic testing. The region benefits from significant government and private sector investment in medical research and public health. Major players like Thermo Fisher Scientific, Abbott, and Bio-Rad Laboratories drive ongoing innovation and the availability of quality ELISA kits and instruments. Hospitals and labs throughout the U.S. and Canada commonly use ELISA tests to diagnose a variety of infectious and chronic diseases. Moreover, a high level of awareness about early disease detection and favourable reimbursement policies help support widespread use of these tests. Together, these factors make North America the leading region in this market.

Asia Pacific is estimated to register the highest CAGR in the ELISA diagnostics tests market during the forecast period in 2024.

The Asia-Pacific region is seeing the fastest growth in the ELISA Diagnostic Tests market. This growth is due to an increase in infectious and lifestyle related diseases. Countries such as China, India, and Southeast Asian nations are expanding their healthcare infrastructure and investing more in diagnostic technologies. There is a rising awareness among healthcare professionals and the public about the importance of early diagnosis, which is increasing the demand for ELISA-based tests. Government health initiatives and large screening programs are also promoting the use of reliable diagnostic tools like ELISA. Furthermore, the low cost of ELISA kits makes them a popular option in budget-conscious healthcare settings. These factors are driving significant market growth in the region.

ELISA Diagnostics Tests Market- Competitive Landscape:

The ELISA Diagnostic Tests market is filled with competition, featuring a mix of global and local players focused on product innovation, forming partnerships, and expanding their reach. Major names like Thermo Fisher Scientific, Abbott, Bio-Rad Laboratories, Danaher Corporation (Beckman Coulter), and F. Hoffmann-La Roche Ltd. are at the forefront. They have extensive portfolios of ELISA tests and strong global distribution networks. These companies invest heavily in research and development to create ELISA systems that are more sensitive, automated, and user-friendly for clinical and research applications. Emerging and mid-sized companies like Bio-Techne, RayBiotech, OriGene Technologies, and Elabscience are also gaining traction. They target specific disease areas and offer custom assay development. Additionally, firms like GenScript Biotech and Eurofins Scientific are evolving in the Asia-Pacific and European markets through collaborations and local manufacturing efforts.

Technological innovations, such as multiplex ELISA, portable ELISA platforms, and automation systems, further shape this competitive landscape. As disease prevalence increases and the need for early diagnosis becomes urgent, the competition intensifies. Companies are focusing on affordability, speed, and accuracy.

Recent Developments:

In May 2024, Merck KGaA announced the acquisition of Mirus Bio for approximately USD 600 million. While focused on viral vector manufacturing, the acquisition strengthens Merck's downstream analytics capabilities, including ELISA-based platforms. This deal supports the company's strategic vision to enhance its life sciences portfolio and advance solutions in gene therapy and bioprocessing diagnostics

In April 2023, Thermo Fisher Scientific Inc. introduced a next-generation ELISA kit platform aimed at providing enhanced sensitivity and faster results for both clinical and research settings. The new kits incorporate advanced signal detection technology, which shortens assay times and improves consistency across various biomarker analyses. This launch highlights Thermo Fisher's ongoing commitment to advancing diagnostic precision and operational efficiency in laboratories around the globe

In February 2023, Abcam plc expanded its ELISA product portfolio with the launch of a new range of recombinant monoclonal antibody-based ELISA kits. Designed for cancer and autoimmune disease research, these kits deliver enhanced specificity and consistency across experiments. The launch underscores Abcam's commitment to reproducibility and high-quality research tools, supporting the advancing needs of academic and biopharmaceutical research communities

In February 2023, Merck KGaA through its life science division MilliporeSigma, launched multiplex ELISA kits specifically designed for detecting cytokines and chemokines in preclinical research. These kits enable the simultaneous measurement of multiple analytes, improving both data depth and assay efficiency. This launch enhances Merck's presence in the diagnostic and life sciences space, aligning with the growing demand for advanced tools in biomarker discovery and translational research.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL ELISA DIAGNOSTICS TESTS MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • Abbott
  • Abcam Limited
  • BD
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • BioVision, Inc.
  • Creative Diagnostics
  • Danaher Corporation
  • Elabscience Biotechnology Inc.
  • Enzo Biochem, Inc.
  • Eurofins Scientific SE
  • F. Hoffmann-La Roche Ltd
  • GenScript Biotech Corporation
  • Merck KGaA
  • MyBioSource, Inc.
  • OriGene Technologies, Inc.
  • PerkinElme.
  • RayBiotech, Inc.
  • Siemens Healthineers AG
  • Thermo Fisher Scientific Inc.
  • Others

GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY TEST TYPE- MARKET ANALYSIS, 2019 - 2032

  • Competitive ELISA
  • Indirect ELISA
  • Multiple & Portable ELISA
  • Sandwich ELISA

GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY APPLICATION- MARKET ANALYSIS, 2019 - 2032

  • Immunology
  • Inflammation
  • Infectious diseases
  • Cancer
  • Protein quantification
  • Other Applications

GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY END USER- MARKET ANALYSIS, 2019 - 2032

  • Hospitals & Diagnostic Centers
  • Pharmaceutical & Biotechnology Companies
  • Veterinary Hospitals & Diagnostic Laboratories

GLOBAL ELISA DIAGNOSTICS TESTS MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. ELISA Diagnostics Tests Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. ELISA Diagnostics Tests Market Snippet by Test Type
    • 2.1.2. ELISA Diagnostics Tests Market Snippet by Application
    • 2.1.3. ELISA Diagnostics Tests Market Snippet by End User
    • 2.1.4. ELISA Diagnostics Tests Market Snippet by Country
    • 2.1.5. ELISA Diagnostics Tests Market Snippet by Region
  • 2.2. Competitive Insights

3. ELISA Diagnostics Tests Key Market Trends

  • 3.1. ELISA Diagnostics Tests Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. ELISA Diagnostics Tests Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. ELISA Diagnostics Tests Market Opportunities
  • 3.4. ELISA Diagnostics Tests Market Future Trends

4. ELISA Diagnostics Tests Industry Study

  • 4.1. PESTEL Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. ELISA Diagnostics Tests Market: Impact of Escalating Geopolitical Tensions

  • 5.1. Impact of COVID-19 Pandemic
  • 5.2. Impact of Russia-Ukraine War
  • 5.3. Impact of Middle East Conflicts

6. ELISA Diagnostics Tests Market Landscape

  • 6.1. ELISA Diagnostics Tests Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. ELISA Diagnostics Tests Market - By Test Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Test Type, 2024 & 2032 (%)
    • 7.1.2. Competitive ELISA
    • 7.1.3. Indirect ELISA
    • 7.1.4. Multiple & Portable ELISA
    • 7.1.5. Sandwich ELISA

8. ELISA Diagnostics Tests Market - By Application

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Application, 2024 & 2032 (%)
    • 8.1.2. Immunology
    • 8.1.3. Inflammation
    • 8.1.4. Infectious diseases
    • 8.1.5. Cancer
    • 8.1.6. Protein quantification
    • 8.1.7. Other Applications

9. ELISA Diagnostics Tests Market - By End User

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End User, 2024 & 2032 (%)
    • 9.1.2. Hospitals & Diagnostic Centers
    • 9.1.3. Pharmaceutical & Biotechnology Companies
    • 9.1.4. Veterinary Hospitals & Diagnostic Laboratories

10. ELISA Diagnostics Tests Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. ELISA Diagnostics Tests Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. ELISA Diagnostics Tests Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.8. UK
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. UK Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. UK Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.8.5. UK Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.9. France
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. France Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. France Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.9.5. France Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.10. Italy
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. Italy Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. Italy Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.10.5. Italy Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.11. Spain
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. Spain Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. Spain Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.11.5. Spain Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.12. The Netherlands
      • 10.3.12.1. Overview
      • 10.3.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.3. The Netherlands Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.12.4. The Netherlands Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.12.5. The Netherlands Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Overview
      • 10.3.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.13.5. Sweden Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.14. Russia
      • 10.3.14.1. Overview
      • 10.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.3. Russia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Russia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.14.5. Russia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.15.5. Poland Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. ELISA Diagnostics Tests Key Manufacturers in Asia Pacific
    • 10.4.3. APAC Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.4.5. APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.4.6. APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.7. China
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. China Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. China Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.7.5. China Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.8. India
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. India Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. India Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.8.5. India Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.12. Indonesia
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Indonesia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Indonesia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Indonesia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.13. Thailand
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Thailand Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Thailand Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Thailand Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.5. Latin America (LATAM)
    • 10.5.1. Overview
    • 10.5.2. ELISA Diagnostics Tests Key Manufacturers in Latin America
    • 10.5.3. LATAM Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.5.5. LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.5.6. LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa (MEA)
    • 10.6.1. Overview
    • 10.6.2. ELISA Diagnostics Tests Key Manufacturers in Middle East and Africa
    • 10.6.3. MEA Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
    • 10.6.5. MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
    • 10.6.6. MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.8. UAE
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. UAE Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. UAE Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.8.5. UAE Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Test Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Application, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End User, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- ELISA Diagnostics Tests Industry

  • 11.1. Competitive Benchmarking
    • 11.1.1. Competitive Dashboard
    • 11.1.2. Competitive Positioning
  • 11.2. Company Profiles
    • 11.2.1. Abbott
    • 11.2.2. Abcam Limited
    • 11.2.3. BD
    • 11.2.4. Bio-Rad Laboratories, Inc.
    • 11.2.5. Bio-Techne Corporation
    • 11.2.6. BioVision, Inc.
    • 11.2.7. Creative Diagnostics
    • 11.2.8. Danaher Corporation
    • 11.2.9. Elabscience Biotechnology Inc.
    • 11.2.10. Enzo Biochem, Inc.
    • 11.2.11. Eurofins Scientific SE
    • 11.2.12. F. Hoffmann-La Roche Ltd
    • 11.2.13. GenScript Biotech Corporation
    • 11.2.14. Merck KGaA
    • 11.2.15. MyBioSource, Inc.
    • 11.2.16. OriGene Technologies, Inc.
    • 11.2.17. PerkinElme.
    • 11.2.18. RayBiotech, Inc.
    • 11.2.19. Siemens Healthineers AG
    • 11.2.20. Thermo Fisher Scientific Inc.
    • 11.2.21. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us